News

Patients with obesity can now get Zepbound’s strongest doses for a flat rate through Lilly’s self-pay pharmacy. Eli Lilly ...
Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...
This article explains the main ways that Zepbound and Wegovy are alike and different. Your doctor can explain the benefits and risks of these and other treatment options based on your individual ...
Eli Lilly's drive to provide as many treatment options as possible for its weight-loss drug Zepbound has continued with the launch of new high-dose vials sold at a $150 discount to its auto ...
GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...
For those who prefer the convenience of getting Zepbound online, several verified options have passed our ... with the pens offering a wider range of doses and the vials requiring syringe ...
Innovent completes first patient dosing in seventh phase 3 trial (GLORY-OSA) of mazdutide in China with moderate-to-severe OSA & obesity: San Francisco, US Tuesday, June 17, 2025, ...
Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or ...
Poison-control centers are seeing a steady increase in calls related to weight-loss drugs, and the FDA shared a report detailing severe gastrointestinal issues people are experiencing when using ...
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...